Abiopharma

Twin Disc to Present at Noble Emerging Growth Virtual Conference

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST

Invitation to an annual and special general meeting for 2.7.26 – reappointments, voting instrument

CHIPOTLES "SUMMER OF EXTRAS" RETURNS, WITH STREAK-BASED REWARDS AND LOCAL RANKINGS TO GAMIFY THE REWARDS EXPERIENCE

BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors

SLB and Vår Energi Expand Digital Collaboration to Scale Well and Integrated Field Development Planning

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call

Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference

Nordic American Tankers Ltd (NYSE: NAT) – Report as per March 31, 2026 – NAT continues to prosper and raises its dividend. Market conditions for NAT are now the best for several decades.

Midland complète un levé géophysique de polarisation provoquée et identifie plusieurs anomalies sur son projet Caniapisc Au